Clinical Trials

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05647590 2024-01-30

SBRT/RT in Oligometastatic Stage IV NSCLC

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06207292 2024-01-16

STARTNEWERA-OM

Carcinoma, Non-Small-Cell Lung

NCT05128630 2023-09-28

DEDALUS

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03975114 2023-03-24

MILES-5

460 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05532527 2022-09-08

NSCLC

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Unknown

500 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05170581 2021-12-28

Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05098990 2021-10-29

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Phase 4 Unknown

328 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

320 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04951648 2021-07-07

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

220 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04950400 2021-07-06

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04672759 2020-12-17

A Real-world Study of Durvalumab for Lung Cancer in China

Unknown

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT03267654 2020-08-03

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

Carcinoma, Non-Small-Cell Lung

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03664115 2018-09-10

Itraconazole in Non Small Cell Lung Cancer

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02844114 2017-03-31

LCKY2015-21(x)

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02906150 2016-09-19

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

330 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02841228 2016-07-22

Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01707329 2015-09-09

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

180 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01843647 2015-07-15

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

Carcinoma, Non-Small-Cell Lung

NCT01998061 2013-12-20

Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00039039 2013-12-18

Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

300 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01850147 2013-05-09

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00452803 2010-07-12

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)

102 enrolled